Results 151 to 157 of about 21,301 (157)

Acneiform Eruptions: A Common Cutaneous Toxicity of the MEK Inhibitor Trametinib

Australasian Journal of Dermatology, 2014
Georgina V. Long, Richard F. Kefford, Pablo Uribe   +2 more
exaly  

Concomitant Oral and Intravenous Pharmacokinetics of Trametinib, a MEK Inhibitor, in Subjects With Solid Tumours

British Journal of Clinical Pharmacology, 2014
Graeme Young, Daniele Ouellet, Keith Orford   +2 more
exaly  

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non–Small Cell Lung Cancer

Journal of Thoracic Oncology, 2017
Jean-Pierre Delord, Karen Kelly, Natasha B Leighl   +2 more
exaly  

Paclitaxel With or Without Trametinib or Pazopanib in Advanced Wild-Type BRAF Melanoma (PACMEL): A Multicentre, Open-Label, Randomised, Controlled Phase II Trial

Annals of Oncology, 2019
Dirk Schadendorf, M R Middleton, S B Love   +2 more
exaly  

Trametinib: A MEK Inhibitor for Management of Metastatic Melanoma

OncoTargets and Therapy, 2015
Iwona Lugowska, Katarzyna Kozak, Piotr Rutkowski   +2 more
exaly  

Drosophila Lung Cancer Models Identify Trametinib Plus Statin as Candidate Therapeutic

Cell Reports, 2016
Ross Cagan
exaly  

Five-Year Analysis of Neoadjuvant Dabrafenib and Trametinib for Stage III Melanoma

Annals of Oncology
Serigne Lo, Alexander M Menzies, Georgina V. Long   +2 more
exaly